Clinical Trial Update: Phase 2 Study of Fingolimod in Lung Cancers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Fingolimod in non-small cell lung cancer and small-cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Fingolimod (fingolimod)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Non Small Cell Lung Cancer, Small-cell Lung Cancer | Phase 2 | Status: RECRUITING